01 30GLAXO GRP LTD
02 15GLAXOSMITHKLINE
03 3HALEON US HOLDINGS
01 27488827
02 18062264
03 18147461
04 18347879
05 68511304
06 58534281
07 58746242
08 29750726
09 111090294
10 611116721
11 311116721*PED
12 212396986
13 38511304*PED
14 58534281*PED
15 58746242*PED
01 2Y
02 46Blank
01 31Y
02 17Blank
01 12026-04-05
02 62027-06-14
03 32027-12-14
04 22027-12-18
05 12028-07-15
06 12028-10-15
07 62029-02-26
08 32029-08-26
09 52030-03-08
10 52030-09-08
11 52030-10-11
12 52030-11-29
13 52031-04-11
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1424
Delist Requested :
Patent Use Description : LONG-TERM, ONCE DAILY ...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1401
Delist Requested :
Patent Use Description : INDICATED FOR LONG-TER...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2030-11-29
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 11090294
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-3202
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-14
